Nursing Home–Acquired Pneumonia

ABSTRACT

Nursing home–acquired pneumonia (NHAP) was first described in 1978. Since then there has been much written regarding NHAP and its management despite the lack of well-designed studies in this patient population. The most characteristic features of patients with NHAP are the atypical presentation, which may lead to delay in diagnosis and therapy. The microbial etiology of pneumonia encompasses a wide spectrum that spans microbes recovered from patients with community-acquired pneumonia to organisms considered specific only to nosocomial settings. Decision to transfer a nursing home patient to an acute care facility depends on a host of factors, which include the level of staffing available at the nursing home, patients' advance directives, and complexity of treatment. The presence of risk factors for multidrug-resistant pathogens dictates approach to therapy. Prevention remains the cornerstone of reducing the incidence of disease. Despite the advance in medical services, mortality from NHAP remains high.

KEYWORDS

Nursing home pneumonia - healthcare-associated pneumonia - antibiotic - hospital transfer

REFERENCES

• 1 Ronald L A, McGregor M J, McGrail K M, Tate R B, Broemling A M. Hospitalization rates of nursing home residents and community-dwelling seniors in British Columbia.  Can J Aging. 2008;  27 109-115
• 2 Kerr H D, Byrd J C. Nursing home patients transferred by ambulance to a VA emergency department.  J Am Geriatr Soc. 1991;  39 132-136
• 3 Marrie T J, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study.  Rev Infect Dis. 1989;  11 586-599
• 4 Muder R R. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention.  Am J Med. 1998;  105 319-330
• 5 Muder R R. Approach to the problem of pneumonia in long-term care facilities.  Compr Ther. 2000;  26 255-262
• 6 Marrie T J. Pneumonia in the long-term-care facility.  Infect Control Hosp Epidemiol. 2002;  23 159-164
• 7 Thompson R S, Hall N K, Szpiech M, Reisenberg L A. Treatments and outcomes of nursing-home-acquired pneumonia.  J Am Board Fam Pract. 1997;  10 82-87
• 8 Mehr D R, Zweig S C, Kruse R L et al.. Mortality from lower respiratory infection in nursing home residents: a pilot prospective community-based study.  J Fam Pract. 1998;  47 298-304
• 9 Loeb M, McGeer A, McArthur M, Walter S, Simor A E. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities.  Arch Intern Med. 1999;  159 2058-2064
• 10 Beck-Sague C, Banerjee S, Jarvis W R. Infectious diseases and mortality among US nursing home residents.  Am J Public Health. 1993;  83 1739-1742
• 11 Magaziner J, Tenney J H, DeForge B et al.. Prevalence and characteristics of nursing-home acquired infections in the aged.  J Am Geriatr Soc. 1991;  39 1071-1078
• 12 Jacobson C, Strausbaugh L J. Incidence and impact of infection in a nursing home care unit.  Am J Infect Control. 1990;  18 151-159
• 13 Setia U, Serventi I, Lorenz P. Nosocomial infections among patients in a long-term care facility: spectrum, prevalence, and risk factors.  Am J Infect Control. 1985;  13 57-62
• 14 Vergis E N, Brennen C, Wagener M, Muder R R. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival.  Arch Intern Med. 2001;  161 2378-2381
• 15 Rantanen T K, Salo J A. Gastroesophageal reflux disease as a cause of death: analysis of fatal cases under conservative treatment.  Scand J Gastroenterol. 1999;  34 229-233
• 16 Marrie T J, Blanchard W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia.  J Am Geriatr Soc. 1997;  45 50-55
• 17 Lim W S, Macfarlane J T. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia.  Eur Respir J. 2001;  18 362-368
• 18 Gross P A, Van Antwerpen C. Nosocomial infections and hospital deaths: a case-control study.  Am J Med. 1983;  75 658-662
• 19 Garb J L, Brown R, Garb J R et al.. Differences in etiology of pneumonias in nursing home and community patients.  JAMA. 1978;  240 2169-2172
• 20 Troy C J, Peeling R W, Ellis A G, Hockin J C, Bennett D A, Murphy M R, Spika J S. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes.  JAMA. 1997;  277 1214-1218
• 21 Orr P H, Peeling R W, Fast M, Brunka J, Duckworth H, Harding G K, Nicolle L E. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly.  Clin Infect Dis. 1996;  23 1240-1245
• 22 Maruyama T, Niederman M S, Kobayashi T et al.. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly.  Respir Med. 2008;  102 1287-1295
• 23 Maesaki S, Kohno S, Kog H et al.. An outbreak of Legionnaires' pneumonia in a nursing home.  Intern Med. 1992;  31 508-512
• 24 Loeb M, Simor A E, Mandell L et al.. Two nursing home outbreaks of respiratory infections with Legionella sainthelensi .  J Am Geriatr Soc. 1999;  47 547-552
• 25 Seenivasan M H, Yu V L, Muder R R. Legionnaires' disease in long-term care facilities: overview and proposed solutions.  J Am Geriatr Soc. 2005;  53 875-880
• 26 Falsey A R, Treanor J J, Betts R F, Walsh E E. Viral respiratory infections in institutionalized elderly: clinical and epidemiologic findings.  J Am Geriatr Soc. 1992;  40 115-119
• 27 El Solh A A, Sikka P, Ramadan F, Davies J. Etiology of severe pneumonia in the very elderly.  Am J Respir Crit Care Med. 2001;  163 645-651
• 28 El Solh A A, Aquilina A T, Dhillon R S, Ramadan F, Nowak P, Davies J. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia.  Am J Respir Crit Care Med. 2002;  166 1038-1043
• 29 El Solh A A, Pietrantoni C, Bhat A, Bhora M, Berbary E. Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia.  Clin Infect Dis. 2004;  39 474-480
• 30 Metlay J P, Kapoor W N, Fine M J. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination.  JAMA. 1997;  278 1440-1445
• 31 Bentley D W. Bacterial pneumonia in the elderly: clinical features, diagnosis, etiology and treatment.  Gerontology. 1984;  30 297-307
• 32 Mubareka S, Duckworth H, Cheang M et al.. Use of diagnostic tests for presumed lower respiratory tract infection in long-term care facilities.  J Am Geriatr Soc. 2007;  55 1365-1370
• 33 Degelau J, Guay D, Straub K, Luxenberg M. Effectiveness of oral antibiotic treatment in nursing home acquired pneumonia.  J Am Geriatr Soc. 1995;  43 245-251
• 34 Thompson R S, Hall N K, Szpiech M. Hospitalization and mortality rates for nursing home acquired pneumonia.  J Fam Pract. 1999;  48 291-293
• 35 Loeb M, Carusone S C, Goeree R et al.. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial.  JAMA. 2006;  295 2503-2510
• 36 Fried T R, Gillick M, Lipsitz L A. Whether to transfer? Factors associated with hospitalization and outcome of elderly long-term care patients with pneumonia.  J Gen Intern Med. 1995;  10 246-250
• 37 Fried T R, Gillick M R, Lipsitz L A. Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer.  J Am Geriatr Soc. 1997;  45 302-306
• 38 Intrator O, Castle N, Mor V. Facility characteristics associated with hospitalization of nursing home residents: results of a national study.  Med Care. 1999;  37 228-237
• 39 Fine M J, Auble T E, Yealy D M et al.. A prediction rule to identify low-risk patients with community-acquired pneumonia.  N Engl J Med. 1997;  336 243-250
• 40 Mehr D R, Binder E F, Kruse R L et al.. Predicting mortality in nursing home residents with lower respiratory tract infection.  JAMA. 2001;  286 2427-2436
• 41 Bentley D W, Bradley S, High K et al.. Practice guideline for evaluation of fever and infection in long-term care facilities.  Clin Infect Dis. 2000;  31 640-653
• 42 Intrator O, Mor V. Effect of state Medicaid reimbursement rates on hospitalizations from nursing homes.  J Am Geriatr Soc. 2004;  52 393-398
• 43 Mandell L A, Marrie T J, Grosman R F, Chow A W, Hyland R H. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.  Clin Infect Dis. 2000;  31 383-421
• 44 Mandell L A, Bartlett J G, Dowell S F, File Jr T M, Musher D M, Whitney C. Infectious Diseases Society of America . Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.  Clin Infect Dis. 2003;  37 1405-1433
• 45 American Thoracic Society and Infectious Diseases Society of America . Guidelines for the management of adults with hospital acquired, ventilator-associated, and health care associated pneumonia.  Am J Respir Crit Care Med. 2005;  171 388-416
• 46 Chen D K, McGeer A, de Azavedo J C, Low D E. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada.  N Engl J Med. 1999;  341 233-239
• 47 Cohen A E, Lautenbach E, Morales K H, Linkin D R. Fluoroquinolone-resistant Escherichia coli in the long-term care setting.  Am J Med. 2006;  119 958-963
• 48 Medina-Walpole A M, Katz P R. Nursing home–acquired pneumonia.  J Am Geriatr Soc. 1999;  47 1005-1015
• 49 Peterson P K, Stein D, Guay D R et al.. Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin.  Am J Med. 1988;  85 164-171
• 50 Naughton B J, Mylotte J M. Treatment guideline for nursing home–acquired pneumonia based on community practice.  J Am Geriatr Soc. 2000;  48 82-88
• 51 Hirata-Dulas C A, Stein D J, Guay D R, Gruninger R P, Peterson P K. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.  J Am Geriatr Soc. 1991;  39 979-985
• 52 Yakovlev S V, Stratchounski L S, Woods G L et al.. Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.  Eur J Clin Microbiol Infect Dis. 2006;  25 633-641
• 53 Vanderkooi O G, Low D E, Green K, Powis J E, McGeer A. Toronto Invasive Bacterial Disease Network . Predicting antimicrobial resistance in invasive pneumococcal infections.  Clin Infect Dis. 2005;  40 1288-1297
• 54 Waterer G W, Somes G W, Wunderink R G. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia.  Arch Intern Med. 2001;  161 1837-1842
• 55 Waterer G W. Optimal antibiotic treatment in severe pneumococcal pneumonia: time for real answers.  Eur J Clin Microbiol Infect Dis. 2005;  24 691-692
• 56 Chastre J, Wolff M, Fagon J Y et al.. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.  JAMA. 2003;  290 2588-2598
• 57 Muder R R, Brennen C, Swenson D L, Wagener M. Pneumonia in a long-term care facility: a prospective study of outcome.  Arch Intern Med. 1996;  156 2365-2370
• 58 Mehr D R, Zweig S C, Kruse R L et al.. Mortality from lower respiratory infection in nursing home residents: a pilot prospective community-based study.  J Fam Pract. 1998;  47 298-304
• 59 Degelau J, Guay D, Straub K, Luxenberg M G. Effectiveness of oral antibiotic treatment in nursing home-acquired pneumonia.  J Am Geriatr Soc. 1995;  43 245-251
• 60 Mehr D R, Foxman B, Colombo P. Risk factors for mortality from lower respiratory infections in nursing home patients.  J Fam Pract. 1992;  34 585-591
• 61 Chan Carusone S B, Walter S D, Brazil K, Loeb M B. Pneumonia and lower respiratory infections in nursing home residents: predictors of hospitalization and mortality.  J Am Geriatr Soc. 2007;  55 414-419
• 62 Meehan T P, Fine M J, Krumholz H M et al.. Quality of care, process, and outcomes in elderly patients with pneumonia.  JAMA. 1997;  278 2080-2084
• 63 Houck P M, Bratzler D W, Nsa W, Ma A, Bartlett J G. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community acquired pneumonia.  Arch Intern Med. 2004;  164 637-644
• 64 Quagliarello V, Ginter S, Han L, Van Ness P, Allore H, Tinetti M. Modifiable risk factors for nursing home-acquired pneumonia.  Clin Infect Dis. 2005;  40 1-6
• 65 Russell S L, Boylan R J, Kaslick R S et al.. Respiratory pathogen colonization of the dental plaque of institutionalized elders.  Spec Care Dentist. 1999;  19 128-134
• 66 El-Solh A A, Pietrantoni C, Bhat A et al.. Colonization of dental plaques: a reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders.  Chest. 2004;  126 1575-1582
• 67 Hawkins R J, Main P A, Locker D. Oral health status and treatment needs of Canadian adults aged 85 years and over.  Spec Care Dentist. 1998;  18 164-169
• 68 Wyatt C C. Elderly Canadians residing in long-term care hospitals, I: Medical and dental status.  J Can Dent Assoc. 2002;  68 353-358
• 69 Bryant S R, MacEntee M I, Browne A. Ethical issues encountered by dentists in the care of institutionalized elders.  Spec Care Dentist. 1995;  15 79-82
• 70 Loeb M B, Becker M, Eady A, Walker-Dilks C. Interventions to prevent aspiration pneumonia in older adults: a systematic review.  J Am Geriatr Soc. 2003;  51 1018-1022
• 71 Shay K. Infectious complications of dental and periodontal diseases in the elderly population.  Clin Infect Dis. 2002;  34 1215-1223
• 72 Yoneyama T, Yoshida M, Ohrui T Oral Care Working Group et al. Oral care reduces pneumonia in older patients in nursing homes.  J Am Geriatr Soc. 2002;  50 430-433
• 73 Adachi M, Ishihara K, Abe S, Okuda K. Professional oral health care by dental hygienists reduced respiratory infections in elderly persons requiring nursing care.  Int J Dent Hyg. 2007;  5 69-74
• 74 Gross P A, Hermogenes A W, Sacks H S, Lau J, Levandowski R A. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature.  Ann Intern Med. 1995;  123 518-527
• 75 Saito R, Suzuki H, Oshitani H et al.. The effectiveness of influenza vaccine against influenza A (H3N2) virus infections in nursing homes in Niigata, Japan during the 1998–1999 and 199–2000 seasons.  Infect Control Hosp Epidemiol. 2002;  23 82-86
• 76 Deguchi Y, Takasugi Y, Nishimura K. Vaccine effectiveness for influenza in the elderly in welfare nursing homes during an influenza A (H3N2) epidemic.  Epidemiol Infect. 2000;  125 393-397
• 77 Ohmit S E, Arden N H, Monto A S. Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic.  J Am Geriatr Soc. 1999;  47 165-171
• 78 Centers for Disease Control and Prevention . Update: influenza activity: United States, 1997–98 season.  MMWR Morb Mortal Wkly Rep. 1998;  47 196-200
• 79 Health Canada . Effectiveness of inactivated trivalent influenza vaccine in long-term care institutions, Toronto, 2003–2004.  Can Commun Dis Rep. 2004;  30 109-116
• 80 Centers for Disease Control and Prevention . Outbreaks of pneumococcal pneumonia among unvaccinated residents of a nursing home-New Jersey, April 2001.  MMWR Morb Mortal Wkly Rep. 2001;  50 707-710
• 81 Gaillat J, Zmirou D, Mallaret M R et al.. Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions [in French].  Rev Epidemiol Sante Publique. 1985;  33 437-444
• 82 Kaufman P. Pneumonia in old age.  Arch Intern Med. 1947;  79 518-531
• 83 Rubins J B, Puri A KG, Loch J et al.. Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly patients.  J Infect Dis. 1998;  178 431-440
• 84 Nuorti J P, Butler J C, Crutcher J M et al.. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents.  N Engl J Med. 1998;  338 1861-1868
• 85 Centers for Disease Control and Prevention (CDC) . Outbreak of pneumococcal pneumonia among unvaccinated residents of a nursing home—New Jersey, April 2001.  MMWR Morb Mortal Wkly Rep. 2001;  50 707-710
• 86 Valenzuela M T, Altuzarra R H, Trucco O A et al.. Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in elderly residents of a long-term care facility.  Braz J Infect Dis. 2007;  11 322-326
• 87 Loeb M, McGeer A, McArthur M, Peeling R W, Petric M, Simor A E. Surveillance for outbreaks of respiratory tract infections in nursing homes.  CMAJ. 2000;  162 1133-1137